Avaant Pharmaceuticals Inc Burlington, MA - 01803

Avaant Pharmaceuticals Inc is categorized under Wholesale Pharmaceutical Products in Burlington, MA and active since 2007.

Avaant Pharmaceuticals Inc was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.

If you are seeking more information, feel free to contact Divya Maheshwari at the company’s single location by writing to 35 Corporate Drive, Burlington, Massachusetts MA 01803 or by phoning (781) 685-4818. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Avaant Pharmaceuticals Inc
Contact Person: Divya Maheshwari
Address: 35 Corporate Drive, Burlington, Massachusetts 01803
Phone Number: (781) 685-4818
Annual Revenue (USD): $100.000 to $499.999
Founded: 2007
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Wholesale Pharmaceutical Products
SIC Code: 5122
NAICS Code: 424210
Share This Business:

Avaant Pharmaceuticals Inc was started in 2007 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Divya Maheshwari for inquiries that concern Avaant Pharmaceuticals Inc by calling the company number (781) 685-4818, as your correspondence is most welcome. Additionally, the physical location of the single location of Avaant Pharmaceuticals Inc can be found at the coordinates as well as the street address 35 Corporate Drive in Burlington, Massachusetts 01803.

For its online presence, you may visit Avaant Pharmaceuticals Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.